Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > 148 global corporations have nanotechnology initiatives today

Lux Research kicks off client-only conference call series with exclusive analysis of best practices in nanotechnology commercialization

148 global corporations have nanotechnology initiatives today; 290 will in 2008

Lux Research

New York, NY | Posted on April 05, 2006

With U.S. President George Bush and Procter & Gamble CEO Alan Lafley highlighting nanotechnology in recent speeches, nanotech is clearly no longer just a far-future science exercise – executives expect measurable commercial results from this field of innovation in the next four years. Earlier today, Lux Research provided clients with the key lessons from a proprietary analysis of nanotechnology’s impact on 76 industries during the launch of Lux Research Interactive, the advisory firm’s new series of client-only conference calls. Based on the new report “How Industry Leaders Organize for Nanotech Innovation”, the Lux Research Interactive session provided clients with best practices on how market leaders are structuring their organizations to take advantage of emerging technologies based on the physical sciences.

“We have seen significant increases in corporate nanotechnology activity in the last 18 months, with companies now firmly staking out their competitive positions,” said Lux Research Senior Analyst Mark Bünger during today’s client-only conference call. “Many large corporations are already selling products that incorporate emerging nanotechnology, and scores of others are in late-stage product development or trials. But even the leaders say they’re not organized effectively, and many of their competitors have not even begun to set up shop.”

To gauge nanotechnology’s effect on global businesses and their readiness for change, Lux Research analyzed 1,331 of the world’s largest companies and interviewed leading executives at 35 of the most pioneering ones directly. These corporations put $3.2 billion into nanotech R&D in 2005 and earned $32 billion in revenues from nanotech-related products. Among Lux Research’s findings:

  • Nanotechnology will impact different industries in radically different ways. In high-impact industries like pharmaceuticals, semiconductors, and aerospace, companies like Merck and Boeing will develop wholly new product lines, find cost reduction/performance improvements on the order of 20% or more, and need to develop new processes for innovations like drug-device hybrids and roll-to-roll printable electronic devices. Even in medium-impact sectors like automotive and food, companies like Ford and Kraft are seeing large incremental improvements that will be felt at the bottom line as nanotechnology makes hybrid vehicles run longer and functional foods deliver more nutrition.
  • Today 148 firms have structured nanotech initiatives, doubling to 290 in 2008. By then, corporate nanotech R&D spending will increase to $12 billion; 80% of high-impact companies will have nanotech in normal product development, and many of the 217 firms seeing a medium level of impact from nanotechnology will have formalized today’s loose projects.

“Nanotech innovations will force incremental, disruptive, and structural changes onto entire industries,” said Bünger on the call. “Companies need to start today to develop new strategies for product development, intellectual property, marketing, supplier relationships, and of course, R&D.”

Lux Research Interactive marks Lux Research’s newest service available to global corporations, investors, and governments. Through our analysts’ unique expertise and unrivaled network, Lux Research enables our clients to:

  • Source new technologies and intellectual property
  • Monitor competitors, partners, and customers
  • Organize internal efforts, exploiting best practices and case studies from pioneers
  • Partner with leading technology start-ups, corporations, and labs in North America, Europe and Asia
  • Profit by beating competitors to innovative new products and services

For information on how to become a client, contact Rob Burns, Vice President of Sales, at +1 (646) 723-0708.


About Lux Research:
Lux Research is the world’s leading nanotechnology research and advisory firm. We help our clients make better decisions to profit from nanoscale science and technology, tapping into our analysts’ unique expertise and unrivaled network. Our clients include top decision makers at large corporations, portfolio managers and analysts at leading financial institutions, CEOs of the most innovative start-ups, and visionary public policy makers.

For more information, please click here.

Lux Research Inc.
Peter Hebert

Copyright © Lux Research

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Nanometrics Announces Upcoming Investor Events November 18th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces Multi-Year Agreement With Lockheed Martin November 16th, 2015

Arrowhead Late-Breaking Clinical Data Shows that ARC-520 Can Produce Deep and Durable Reductions of Hepatitis B Viral Antigens and DNA November 16th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces the Sale of Its Latest Quantum Computer to Los Alamos National Laboratory November 11th, 2015


Scientists design a QKD-based quantum private query with no failure November 25th, 2015

MIT mathematicians identify limits to heat flow at the nanoscale: New formula identifies limits to nanoscale heat transfer, may help optimize devices that convert heat to electricity November 25th, 2015

Physicists explain the unusual behavior of strongly disordered superconductors: Using a theory they developed previously, the scientists have linked superconducting carrier density with the quantum properties of a substance November 25th, 2015

Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic